I have many years of experience in taking care of patients with liver disease. But in addition to being on the cutting edge of my field I like to listen to the patient and see what he or she really wants - not only what I think should be done.
Medical Publications:
Case BC, Yang M, Qamer SZ, Kumar S, Yerasi C, Forrestal BJ, Chezar-Azerrad C, Medranda GA, Bernardo NL, Rogers T, Satler LF, Hashim H, Satoskar RS, Lalos AT, Waksman R, Ben-Dor I. Pre-Operative Cardiovascular Testing before Liver Transplantation. Am J Cardiol. 2021 Aug 1;152:132-137. doi:10.1016/j.amjcard.2021.04. 012. Epub 2021 Jun 5. PMID: 34103158. Higley C, Hsu CC, Smith C, Nadella S, Lalos AT. Safety and efficacy of sofosbuvir/velpatasvir/voxilaprevir in post-liver transplant patients with previous direct-acting antiviral failure: Six case reports. World J Hepatol. 2020;12(12):1341-1348. Vakiti A, Cho MH, Lee W Liang JJ, Lalos AT, and Fishbein, DA. Use of direct-acting antivirals for hepatitis C viral infection and association with intrahepatic cholangiocarcinoma: Is there a linkage? J Oncol Pharm Pract. 2018 Sep Morales AL, Liriano-Ward L, Tierney A, Sang M, Lalos, AT, Hassan M, Nair, V., Schiano T, Satoskar, R. and Smith, C. Ledipasvir/sofosbuvir is effective and well tolerated in post-kidney transplant patients with chronic hepatitis C virus. Clin Transplant. 2017;31 Lalos AT and Smith C. Contrasting the academic and non-academic hepatology practice settings Clinical Liver Disease 2017;9: 144–146. B. BOOKS/CHAPTERS Lalos AT and Schiff ER. Liver disease in gastrointestinal bleeding. Sugawa C Schuman BM, Lucas CE, eds. Gastrointestinal bleeding. New York: lgaku-Shoin, 1992
Clinical Interests
Liver disease and liver transplant evaluation
Medical School
University of Pennsylvania
-
1985
Philadelphia,
PA
